Year archive

ARGENICA THERAPEUTICS LIMITED — 2024 filings

All 65 regulatory filings released by ARGENICA THERAPEUTICS LIMITED (AGN) in 2024, sourced directly from the official regulator.

65 Filings

2024 Period

2024 filings (65)

Filing	Released	Lang
Phase 2 Stroke Clinical Trial Update 3 pages 301.3KB Regulatory Filings	2024-12-09	English
Non-Executive Director Appointment 2 pages 211.0KB Board/Management Information	2024-12-01	English
Initial Director's Interest Notice 2 pages 223.8KB Director's Dealing	2024-12-01	English
$2.76m R&D Tax Incentive Cash Rebate Received for FY24 1 Regulatory Filings	2024-11-20	English
Results of Annual General Meeting 2 pages 281.8KB Declaration of Voting Results & Voting Rights Announcements	2024-11-12	English
AGM Chair's Address & MD Presentation 27 pages 4.2MB AGM Information	2024-11-12	English
Final Director's Interest Notice 2 pages 250.5KB Director's Dealing	2024-11-12	English
Positive DSMB Safety Outcome & Phase 2 Trial Progress Update 3 pages 319.7KB Capital/Financing Update	2024-10-31	English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 461.1KB Interim / Quarterly Report Q1 2025	2024-10-30	English
Quarterly Activities/Appendix 4C Cash Flow Report - updated 11 pages 471.9KB Interim / Quarterly Report Q1 2025	2024-10-30	English
FDA Grants ODD & RPDD for Second Drug in Treatment of HIE 3 pages 295.5KB Regulatory Filings	2024-10-29	English
Investor Presentation 24 pages 3.0MB Investor Presentation	2024-10-28	English
Non-Executive Director Retirement 1 page 190.0KB Board/Management Information	2024-10-23	English
Notice of Annual General Meeting/Proxy Form 20 pages 734.0KB AGM Information	2024-10-10	English
Argenica Appoints VP of Product Development 2 pages 206.2KB Board/Management Information	2024-10-06	English
Positive Results in Key IND Enabling Studies 4 pages 363.0KB Capital/Financing Update	2024-09-24	English
Application for quotation of securities - AGN 6 pages 18.3KB Share Issue/Capital Change	2024-09-23	English
Date of AGM & Closing Date For Director Nominations 1 AGM Information	2024-09-16	English
New Appointments to the Board of Directors 2 pages 197.6KB Board/Management Information	2024-09-16	English
Initial Director's Interest Notice x2 4 pages 321.5KB Director's Dealing	2024-09-16	English
Positive DSMB Safety Outcome & Phase 2 Trial Progress Update 3 pages 969.8KB Regulatory Filings	2024-09-05	English
Appendix 4E & Annual Report to 30 June 2024 48 pages 2.5MB Annual Report FY 2024	2024-08-27	English
Appendix 4G & Corporate Governance Statement 24 pages 676.5KB Regulatory Filings	2024-08-27	English
Results of Meeting 2 pages 270.1KB Declaration of Voting Results & Voting Rights Announcements	2024-08-13	English
Notification regarding unquoted securities - AGN 7 pages 22.5KB Share Issue/Capital Change	2024-08-13	English
Change of Director's Interest Notice 2 pages 290.5KB Director's Dealing	2024-08-13	English
Application for quotation of securities - AGN 7 pages 22.2KB Share Issue/Capital Change	2024-08-07	English
Notification of cessation of securities - AGN 4 pages 14.9KB Share Issue/Capital Change	2024-08-07	English
Cleansing Notice 1 page 197.0KB Regulatory Filings	2024-08-07	English
Change of Director's Interest Notice x3 9 pages 383.8KB Director's Dealing	2024-08-07	English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 482.5KB Interim / Quarterly Report Q4 2024	2024-07-30	English
Phase 2 Stroke Clinical Trial Update 4 pages 280.8KB Regulatory Filings	2024-07-23	English
Investor Webinar Presentation 1 page 217.5KB Investor Presentation	2024-07-21	English
Investor Presentation 17 pages 2.7MB Investor Presentation	2024-07-14	English
Notice of General Meeting/Proxy Form 24 pages 784.3KB Proxy Solicitation & Information Statement	2024-07-11	English
Notice of initial substantial holder from IFL 3 pages 174.4KB Major Shareholding Notification	2024-07-08	English
Application for quotation of securities - AGN 6 pages 18.6KB Share Issue/Capital Change	2024-06-13	English
Notification of cessation of securities - AGN 4 pages 14.9KB Share Issue/Capital Change	2024-06-13	English
Cleansing Notice 1 page 188.8KB Regulatory Filings	2024-06-13	English
Notification of cessation of securities - AGN 4 pages 14.8KB Share Issue/Capital Change	2024-06-11	English
Application for quotation of securities - AGN 6 pages 19.1KB Share Issue/Capital Change	2024-06-04	English
Notification of cessation of securities - AGN 4 pages 15.0KB Regulatory Filings	2024-06-04	English
Cleansing Notice 1 page 188.8KB Regulatory Filings	2024-06-04	English
Change of Director's Interest Notice 3 pages 295.3KB Director's Dealing	2024-06-04	English
Non-Executive Director Resignation 1 page 190.1KB Board/Management Information	2024-06-04	English
Final Director's Interest Notice 2 pages 275.0KB Director's Dealing	2024-06-04	English
ARG-007 Reduces Effects of TBI in Preclinical Study 8 pages 391.1KB Regulatory Filings	2024-05-14	English
DSMB Confirms Safety of First Patients Dosed 2 pages 279.1KB Regulatory Filings	2024-04-28	English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 458.1KB Interim / Quarterly Report Q3 2024	2024-04-23	English
Application for quotation of securities - AGN 6 pages 18.3KB Share Issue/Capital Change	2024-04-21	English
Cleansing Notice 1 page 188.8KB Share Issue/Capital Change	2024-04-21	English
Argenica Successfully Completes $12.0m Placement 2 pages 239.0KB Capital/Financing Update	2024-04-11	English
Proposed issue of securities - AGN 5 pages 18.2KB Capital/Financing Update	2024-04-11	English
Proposed issue of securities - AGN 5 pages 19.4KB Capital/Financing Update	2024-04-11	English
Patient Dosing Milestone Achieved in Phase 2 Stroke Trial 3 pages 294.2KB Regulatory Filings	2024-04-09	English
Trading Halt 2 pages 313.2KB Capital/Financing Update	2024-04-09	English
First Patient Dosed in Phase 2 Stroke Trial of ARG-007 3 pages 307.4KB Regulatory Filings	2024-03-27	English
FDA Grants Rare Pediatric Disease Designation For HIE 2 pages 216.3KB Regulatory Filings	2024-03-24	English
Application for quotation of securities - AGN 6 pages 18.3KB Share Issue/Capital Change	2024-03-06	English
Half Yearly Report and Accounts 17 pages 1.0MB Interim / Quarterly Report H1 2024	2024-02-27	English
Application for quotation of securities - AGN 6 pages 18.3KB Share Issue/Capital Change	2024-02-15	English
Phase 2 Manufacturing Completed & Trial Update 4 pages 271.2KB Regulatory Filings	2024-02-11	English
Application for quotation of securities - AGN 6 pages 27.9KB Share Issue/Capital Change	2024-02-01	English
Cleansing Notice 1 page 201.2KB Capital/Financing Update	2024-02-01	English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 514.2KB Interim / Quarterly Report Q2 2024	2024-01-30	English